In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus,...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9d63c65bd58c4f1e8a98992d463f86f9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9d63c65bd58c4f1e8a98992d463f86f92021-12-02T17:55:03ZIn vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response10.1038/s41598-021-94228-y2045-2322https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f92021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94228-yhttps://doaj.org/toc/2045-2322Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus, the purpose of our in vitro study is to investigate whether there are underlying mechanisms explaining the anti-inflammatory effect of clodronate and possibly involving hydrogen sulphide (H2S). Immortalised fibroblast-like synoviocyte cells (K4IM) were cultured and treated with clodronate in presence of TNF-α. Clodronate significantly modulated iNOS expression elicited by TNF-α. Inflammatory markers induced by TNF-α, including IL-1, IL-6, MCP-1 and RANTES, were also suppressed following administration of clodronate. Furthermore, the reduction in enzymatic biosynthesis of CSE-derived H2S, together with the reduction in CSE expression associated with TNF-α treatment, was reverted by clodronate, thus rescuing endogenous H2S pathway activity. Clodronate displays antinflammatory properties through the modulation of H2S pathway and cytokines levels, thus assuring the control of the inflammatory state. Although further investigation is needed to stress out how clodronate exerts its control on H2S pathway, here we showed for the first the involvement of H2S in the additive beneficial effects observed following clodronate therapy.Rosangela MontanaroAlessio D’AddonaAndrea IzzoCarlo RuosiVincenzo BrancaleoneNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rosangela Montanaro Alessio D’Addona Andrea Izzo Carlo Ruosi Vincenzo Brancaleone In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
description |
Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus, the purpose of our in vitro study is to investigate whether there are underlying mechanisms explaining the anti-inflammatory effect of clodronate and possibly involving hydrogen sulphide (H2S). Immortalised fibroblast-like synoviocyte cells (K4IM) were cultured and treated with clodronate in presence of TNF-α. Clodronate significantly modulated iNOS expression elicited by TNF-α. Inflammatory markers induced by TNF-α, including IL-1, IL-6, MCP-1 and RANTES, were also suppressed following administration of clodronate. Furthermore, the reduction in enzymatic biosynthesis of CSE-derived H2S, together with the reduction in CSE expression associated with TNF-α treatment, was reverted by clodronate, thus rescuing endogenous H2S pathway activity. Clodronate displays antinflammatory properties through the modulation of H2S pathway and cytokines levels, thus assuring the control of the inflammatory state. Although further investigation is needed to stress out how clodronate exerts its control on H2S pathway, here we showed for the first the involvement of H2S in the additive beneficial effects observed following clodronate therapy. |
format |
article |
author |
Rosangela Montanaro Alessio D’Addona Andrea Izzo Carlo Ruosi Vincenzo Brancaleone |
author_facet |
Rosangela Montanaro Alessio D’Addona Andrea Izzo Carlo Ruosi Vincenzo Brancaleone |
author_sort |
Rosangela Montanaro |
title |
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
title_short |
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
title_full |
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
title_fullStr |
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
title_full_unstemmed |
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response |
title_sort |
in vitro evidence for the involvement of h2s pathway in the effect of clodronate during inflammatory response |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f9 |
work_keys_str_mv |
AT rosangelamontanaro invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse AT alessiodaddona invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse AT andreaizzo invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse AT carloruosi invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse AT vincenzobrancaleone invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse |
_version_ |
1718379182168211456 |